Deals this week: Applied BioMath, Mironid, ApoGen Biotechnologies

Applied BioMath and Tusk Therapeutics NV have entered a co-development agreement to quantify and analyse the drug properties and select pre-clinical drug candidates within immuno-oncology.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news